Annual Shareholders Equity
-$73.08 M
-$58.64 M-406.15%
September 30, 2024
Summary
- As of February 7, 2025, OTLK annual stockholders equity is -$73.08 million, with the most recent change of -$58.64 million (-406.15%) on September 30, 2024.
- During the last 3 years, OTLK annual shareholders equity has fallen by -$77.68 million (-1686.07%).
- OTLK annual shareholders equity is now -936.44% below its all-time high of $8.74 million, reached on September 30, 2022.
Performance
OTLK Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
-$73.08 M
+$10.60 M+12.66%
September 1, 2024
Summary
- As of February 7, 2025, OTLK quarterly stockholders equity is -$73.08 million, with the most recent change of +$10.60 million (+12.66%) on September 1, 2024.
- Over the past year, OTLK quarterly shareholders equity has dropped by -$48.73 million (-200.19%).
- OTLK quarterly shareholders equity is now -249.68% below its all-time high of $48.82 million, reached on December 31, 2021.
Performance
OTLK Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
OTLK Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -406.1% | -200.2% |
| 3 y3 years | -1686.1% | -1686.1% |
| 5 y5 years | -578.5% | -256.0% |
OTLK Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -936.4% | at low | -249.7% | +45.6% |
| 5 y | 5-year | -936.4% | at low | -249.7% | +45.6% |
| alltime | all time | -936.4% | at low | -249.7% | +45.6% |
Outlook Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | -$73.08 M(+406.1%) | - |
| Sep 2024 | - | -$73.08 M(-12.7%) |
| Jun 2024 | - | -$83.67 M(-37.7%) |
| Mar 2024 | - | -$134.24 M(+451.4%) |
| Dec 2023 | - | -$24.34 M(+68.6%) |
| Sep 2023 | -$14.44 M(-265.3%) | -$14.44 M(+162.4%) |
| Jun 2023 | - | -$5.50 M(-152.5%) |
| Mar 2023 | - | $10.49 M(-33.4%) |
| Dec 2022 | - | $15.76 M(+80.4%) |
| Sep 2022 | $8.74 M(+89.6%) | $8.74 M(-56.5%) |
| Jun 2022 | - | $20.08 M(-44.2%) |
| Mar 2022 | - | $35.96 M(-26.3%) |
| Dec 2021 | - | $48.82 M(+959.7%) |
| Sep 2021 | $4.61 M(+63.0%) | $4.61 M(-63.9%) |
| Jun 2021 | - | $12.75 M(-38.3%) |
| Mar 2021 | - | $20.65 M(-297.1%) |
| Dec 2020 | - | -$10.47 M(-470.6%) |
| Sep 2020 | $2.83 M | $2.83 M(-74.2%) |
| Jun 2020 | - | $10.97 M(-153.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | -$20.52 M(-19.2%) |
| Dec 2019 | - | -$25.41 M(+135.9%) |
| Sep 2019 | -$10.77 M(-48.2%) | -$10.77 M(+692.9%) |
| Jun 2019 | - | -$1.36 M(-94.1%) |
| Mar 2019 | - | -$23.05 M(+7.3%) |
| Dec 2018 | - | -$21.47 M(+3.2%) |
| Sep 2018 | -$20.81 M(-32.3%) | -$20.81 M(+124.6%) |
| Jun 2018 | - | -$9.26 M(-39.3%) |
| Mar 2018 | - | -$15.27 M(+93.3%) |
| Dec 2017 | - | -$7.90 M(-74.3%) |
| Sep 2017 | -$30.73 M(+494.0%) | -$30.73 M(+6.2%) |
| Jun 2017 | - | -$28.94 M(+7.8%) |
| Mar 2017 | - | -$26.85 M(+23.0%) |
| Dec 2016 | - | -$21.83 M(+322.0%) |
| Sep 2016 | -$5.17 M(-81.9%) | -$5.17 M(-430.9%) |
| Jun 2016 | - | $1.56 M(-107.6%) |
| Mar 2016 | - | -$20.47 M(+70.2%) |
| Dec 2015 | - | -$12.02 M(-58.0%) |
| Sep 2015 | -$28.60 M(0.0%) | -$28.60 M |
| Sep 2014 | -$28.60 M | - |
FAQ
- What is Outlook Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Outlook Therapeutics?
- What is Outlook Therapeutics annual shareholders equity year-on-year change?
- What is Outlook Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Outlook Therapeutics?
- What is Outlook Therapeutics quarterly shareholders equity year-on-year change?
What is Outlook Therapeutics annual stockholders equity?
The current annual shareholders equity of OTLK is -$73.08 M
What is the all time high annual shareholders equity for Outlook Therapeutics?
Outlook Therapeutics all-time high annual stockholders equity is $8.74 M
What is Outlook Therapeutics annual shareholders equity year-on-year change?
Over the past year, OTLK annual stockholders equity has changed by -$58.64 M (-406.15%)
What is Outlook Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of OTLK is -$73.08 M
What is the all time high quarterly shareholders equity for Outlook Therapeutics?
Outlook Therapeutics all-time high quarterly stockholders equity is $48.82 M
What is Outlook Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, OTLK quarterly stockholders equity has changed by -$48.73 M (-200.19%)